FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmacology, namely a method for producing cytochrome C. The method for producing cytochrome C involving degreasing of pig, cattle and horse hearts, removal of ligaments and vessels, grinding and extraction in a trichloracetic acid solution under certain conditions, separation of the extract from stuffing, sorption of the filtered extract at extract pH in the UNOsphere™ S cation exchanger balanced with a starter buffer solution at pH 3.9-4.2, after completion of the sorption process, the cation exchanger is washed with the starter buffer solution; ballast proteins are removed from the UNOsphere™ S cation exchanger by a tris solution, and it is followed with elution of cytochrome C from the UNOsphere™ S cation exchanger with an ammonium sulphate solution, concentration and dialysis purification to remove ammonium sulphate ions completely.
EFFECT: method allows increasing product yield, providing higher purity and reducing production process.
4 cl, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCTION OF CYTOCHROME C | 2013 |
|
RU2528061C1 |
METHOD FOR OBTAINING AGENT WITH ANTIHYPOXIC, REGENERATIVE ACTIVITY | 2020 |
|
RU2745443C1 |
METHOD OF CYTOCHROME C PREPARING | 1994 |
|
RU2096464C1 |
CYTOCHROME C ISOLATION METHOD | 1996 |
|
RU2128512C1 |
METHOD ISOLATING C CYTOCHROME | 0 |
|
SU654612A1 |
METHOD OF CYTOCHROME C PREPARING | 1995 |
|
RU2105559C1 |
METHOD OF HYDROLYTIC ENZYMES PREPARING | 1991 |
|
RU2021372C1 |
METHOD OF RIBONUCLEASE PURIFICATION | 1998 |
|
RU2152995C1 |
METHOD OF PRODUCING A PHARMACEUTICAL SUBSTANCE OF HYALURONIDASE | 2018 |
|
RU2703108C1 |
METHOD FOR PREVENTING MALIGNANT PROCESS DEVELOPMENT EXPERIMENTALLY | 2014 |
|
RU2559086C1 |
Authors
Dates
2011-12-10—Published
2010-05-27—Filed